| 000 | 00740nam a22002297a 4500 | ||
|---|---|---|---|
| 003 | BD-DhJNU | ||
| 005 | 20250715034522.0 | ||
| 008 | 250715b |||||||| |||| 00| 0 eng d | ||
| 020 | _a082470293X | ||
| 020 | _a9780824702939 | ||
| 040 |
_aBD-DhJNU _bENG _cBD-DhJNU _dBD-DhJNU |
||
| 082 |
_223 _a301.25 ACT |
||
| 245 |
_aActive pharmaceutical ingredients : _bdevelopment, manufacturing, and regulation / _cedited by Stanley H. Nusim |
||
| 260 |
_aNew York : _bTaylor & Francis Group, _c2005. |
||
| 300 |
_axv, 433p. : _bill. ; _c24 cm. |
||
| 504 | _aIncludes index | ||
| 650 | _aDrug development organization | ||
| 650 | _aPharmaceutical technology | ||
| 650 | _aDrugs | ||
| 700 |
_aNusim, Stanley H. _eeditor |
||
| 942 |
_2ddc _cBK _n0 |
||
| 999 |
_c1892 _d1892 |
||